5.3796

2.38% 0.1296

Precigen Inc (PGEN)

Overview News Price History Option Chain Financials Discussions Forecast

Precigen Inc stock is traded at $5.3796, with a volume of 1.67M. It is up +2.38% in the last 24 hours and up +39.25% over the past month. Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Previous Close:

$5.25

Open:

$5.33

24h Volume:

1.67M

Relative Volume:

0.36

Market Cap:

$1.92B

Revenue:

$9.68M

Net Income/Loss:

$-250.64M

P/E Ratio:

-3.8431

EPS:

-1.3998

Net Cash Flow:

$-89.83M

1W Performance:

-2.63%

1M Performance:

+39.25%

6M Performance:

+25.58%

1Y Performance:

+233.85%

1-Day Range:

$5.255

$5.54

1-Week Range:

$5.20

$6.04

52-Week Range:

$1.47

$6.04

Precigen Inc Stock (PGEN) Company Profile

Name

Precigen Inc

Sector

Healthcare (1097)

Industry

Biotechnology (615)

Phone

301-556-9900

Address

20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD

Employee

Twitter

@precigen

Next Earnings Date

2026-08-11

Latest SEC Filings

PGEN's Discussions on Twitter

Compare PGEN vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PGEN Precigen Inc	5.375	2.03B	9.68M	-250.64M	-89.83M	-1.3998
VRTX Vertex Pharmaceuticals Inc	519.72	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	642.82	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	940.66	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.65	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	184.64	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-15-25	Upgrade	JP Morgan	Underweight → Neutral
Mar-22-24	Downgrade	JP Morgan	Neutral → Underweight
May-23-23	Initiated	JP Morgan	Neutral
Nov-18-22	Initiated	Cantor Fitzgerald	Overweight
Feb-25-21	Initiated	Stifel	Buy
Feb-22-21	Initiated	Wells Fargo	Overweight
Feb-18-21	Initiated	B. Riley Securities	Buy
May-08-20	Initiated	H.C. Wainwright	Buy

View All

Precigen Inc Stock (PGEN) Latest News

01:02 AM

Precigen CFO Harry Thomasian Jr. sells $1.1m in company stock - Investing.com Canada

Jul 01, 2026

[Form 4] PRECIGEN, INC. Insider Trading Activity - Stock Titan

Jul 01, 2026

Form 4 Precigen Inc For: 1 July By Investing.com - Investing.com Canada

Jul 01, 2026

Precigen COO Rutul Shah sells $251,105 in company stock By Investing.com - Investing.com Canada

Jul 01, 2026

Precigen (PGEN) CFO executes 200,000-share open-market sale under 10b5-1 plan - Stock Titan

Jul 01, 2026

Form 144 PRECIGEN For: 1 July By Investing.com - Investing.com Nigeria

Jul 01, 2026

PGEN (NASDAQ) affiliate files Rule 144 notice to sell 28,571 shares - Stock Titan

Jul 01, 2026

Does Precigen’s (PGEN) Russell Value Index Exit Signal a Shifting Investor Base or Story? - simplywall.st

Jul 01, 2026

Jun 29, 2026

[144] PRECIGEN, INC. SEC Filing - Stock Titan

Jun 29, 2026

Form 144 PRECIGEN For: 29 June By Investing.com - Investing.com South Africa

Jun 29, 2026

Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 26, 2026

Precigen: Entering The Oncology "Sweet Spot" (NASDAQ:PGEN) - Seeking Alpha

Jun 26, 2026

PGEN Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 25, 2026

Price to sales forward of Precigen, Inc. – NASDAQ:PGEN - TradingView

Jun 25, 2026

Precigen Inc Actuals & Estimates (BX:I5X) - TradingView

Jun 25, 2026

Precigen Shareholders Expand Incentive Plan, Reaffirm Governance - The Globe and Mail

Jun 25, 2026

Jun 24, 2026

Precigen (PGEN) investors back 7M-share incentive pool and all board picks - Stock Titan

Jun 24, 2026

Clearfield And 2 Insider Picks For Strong Growth - simplywall.st

Jun 24, 2026

Precigen (PGEN) Is Up 12.1% After Orphan Exclusivity Win for PAPZIMEOS TherapyWhat's Changed - Sahm

Jun 24, 2026

Jun 23, 2026

Precigen stock hits 52-week high at 5.47 USD By Investing.com - Investing.com Australia

Jun 23, 2026

Precigen stock hits 52-week high at 5.47 USD - Investing.com

Jun 23, 2026